Asuragen and Life Technologies Launch Leukemia Test in Europe
Asuragen Inc and Life Technologies Corp announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant Test.
Read MoreSearch Results for: leukemia
Protein Predicts Leukemia Prognosis, May be Therapeutic Target
Posted by Clinical Lab Products | Jul 9, 2010 | Cancer, Miscellaneous |
Researchers at Whitehead Institute and Childrens Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients.
Read MoreResearchers Zero In on Better Way to Predict Prognosis in Pediatric Leukemia Patients
Posted by Clinical Lab Products | Apr 13, 2010 | Cancer, Miscellaneous |
Researchers from the Childrens Cancer Hospital at The University of Texas M. D. Anderson Cancer Center may have found a way to more accurately predict treatment outcomes in young leukemia patients using information from a common and simple complete blood count test, also known as a CBC.
Read MoreChina Approves Leukemia BCR/ABL Fusion Gene Detection FISH Probe
Posted by Clinical Lab Products | Nov 10, 2009 | Cancer, Miscellaneous |
China Medical Technologies Inc, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe from the State Food and Drug Administration of China (SFDA).
Read MoreBlood Testing Identifies Abnormal Cells Six Years Prior to Leukemia Diagnosis
Posted by Clinical Lab Products | Feb 24, 2009 | Cancer, Miscellaneous |
Testing of blood specimens may detect abnormal white blood cells in patients years before the chronic form of lymphocytic leukemia (CLL) develops, according to research published in the current issue of the New England Journal of Medicine.
Read More